Further studies are required to unravel the role of SPARCL1 in regulating adipogenesis in vivo. Nonetheless, a recent study revealed the pathological role of SPARCL1 in the development of non-alcoholic steatohepatitis (NASH) in diet-induced mouse models (158). Here, SPARCL1 is linked to metabolic dysfunction-associated steatohepatitis.